Literature DB >> 870289

Naturally occurring respiratory disease in a kennel caused by Bordetella bronchiseptica.

D A Bemis, L E Carmichael, M J Appel.   

Abstract

The role of Bordetella bronchiseptica as a primary pathogen in nautrally occurring respiratory disease of dogs has been in question since its original isolation in 1911. A study to determine the incidence of B. bronchiseptica in a closed breeding kennel has revealed that the frequency of such isolations is closely associated with mild respiratory disease characterized by a moist, sometimes productive, cough. Infection with B. bronchiseptica usually occurred shortly after weaning and produced illness which lasted for one to two weeks. The organisms, however, continued to be shed for two to three months, and important factor in maintaining the infection in this kennel. Adult dogs sampled at frequent intervals did not harbor B. bronchiseptica in spite of their almost constant exposure to heavily infected pups; immunity to reinfection, therefore, appeared to develop. The involvement of several known canine respiratory viral agents was excluded by virus isolation and serological techniques. It therefore was concluded that B. bronchiseptica was the primary cause of respiratory disease in this large breeding kennel.

Entities:  

Mesh:

Year:  1977        PMID: 870289

Source DB:  PubMed          Journal:  Cornell Vet        ISSN: 0010-8901


  20 in total

Review 1.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 2.  Biology of Bordetella bronchiseptica.

Authors:  R A Goodnow
Journal:  Microbiol Rev       Date:  1980-12

3.  Seroepidemiology of respiratory (group 2) canine coronavirus, canine parainfluenza virus, and Bordetella bronchiseptica infections in urban dogs in a humane shelter and in rural dogs in small communities.

Authors:  John Ellis; Erika Anseeuw; Sheryl Gow; Heather Bryan; Amanda Salb; Noriko Goji; Carrie Rhodes; Stacey La Coste; Judit Smits; Susan Kutz
Journal:  Can Vet J       Date:  2011-08       Impact factor: 1.008

4.  The Bordetella Bps Polysaccharide Is Required for Biofilm Formation and Enhances Survival in the Lower Respiratory Tract of Swine.

Authors:  Tracy L Nicholson; Susan L Brockmeier; Neelima Sukumar; Alexandra E Paharik; Jessica L Lister; Alexander R Horswill; Marcus E Kehrli; Crystal L Loving; Sarah M Shore; Rajendar Deora
Journal:  Infect Immun       Date:  2017-07-19       Impact factor: 3.441

5.  Respiratory disease in kennelled dogs: serological responses to Bordetella bronchiseptica lipopolysaccharide do not correlate with bacterial isolation or clinical respiratory symptoms.

Authors:  Victoria J Chalker; Crista Toomey; Shaun Opperman; Harriet W Brooks; Michael A Ibuoye; Joe Brownlie; Andrew N Rycroft
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

6.  Pathogenesis of change in the upper respiratory tracts of turkeys experimentally infected with an Alcaligenes faecalis isolate.

Authors:  J G Gray; J F Roberts; R C Dillman; D G Simmons
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

Review 7.  Human infections associated with Bordetella bronchiseptica.

Authors:  B F Woolfrey; J A Moody
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

8.  Prophylaxis of Bordetella bronchiseptica infection in guinea pigs by intranasal vaccination with live strain ts-S34.

Authors:  T Shimizu
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

9.  Bordetella bronchiseptica phase variation induced by crystal violet.

Authors:  H Ishikawa; Y Isayama
Journal:  J Clin Microbiol       Date:  1986-02       Impact factor: 5.948

10.  Comparative efficacy of intranasal and injectable vaccines in stimulating Bordetella bronchiseptica-reactive anamnestic antibody responses in household dogs.

Authors:  John A Ellis; Sheryl P Gow; Lindsey B Lee; Stacey Lacoste; Eileen C Ball
Journal:  Can Vet J       Date:  2017-08       Impact factor: 1.008

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.